The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab

The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab

ABSTRACT Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic inflammatory gastrointestinal disorders linked to genetic predisposition and environmental factors. The gut microbiota, composed of various microorganisms, plays a crucial role in IBD,...

Full description

Saved in:
Bibliographic Details
Main Authors: Rebecka Ventin-Holmberg, Julia Eriksson, Anja Eberl, Taina Sipponen, Eija Nissilä, Päivi Saavalainen
Format: Article
Language:English
Published: American Society for Microbiology 2025-08-01
Series:Microbiology Spectrum
Subjects:
infliximab
inflammatory bowel disease
gut microbiota
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01894-24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items